Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses on introducing products based on its lumivascular platform, which is an intravascular image-guided system. The Company manufactures and sells a suite of products in the United States and certain European markets. The Company's products include Lightbox imaging console, as well as its Wildcat, Kittycat and the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO). The lumivascular platform offers real-time visualization of the inside of the artery during PAD treatment. The lumivascular platform consists of a capital component Lightbox and a range of disposable catheter products, including Ocelot, Ocelot PIXL, Ocelot MVRX and Pantheris.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Appliances & Equipment
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: AVGR
- Previous Close: $2.40
- 50 Day Moving Average: $2.753
- 200 Day Moving Average: $3.891
- 52-Week Range: $2.00 - $17.89
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -1.15
- P/E Growth: 0.000
- Market Cap: $53.02M
- Outstanding Shares: 22,804,000
- Beta: -0.35
- Net Margins: -322.49%
- Return on Equity: -1,090.68%
- Return on Assets: -115.12%
Companies Related to Avinger:
- Debt-to-Equity Ratio: 3.42%
- Current Ratio: 8.01%
- Quick Ratio: 6.99%
What is Avinger's stock symbol?
Avinger trades on the NASDAQ under the ticker symbol "AVGR."
Where is Avinger's stock going? Where will Avinger's stock price be in 2017?
3 analysts have issued 1-year price targets for Avinger's stock. Their predictions range from $5.00 to $6.00. On average, they anticipate Avinger's stock price to reach $5.33 in the next year.
When will Avinger announce their earnings?
Avinger is scheduled to release their next quarterly earnings announcement on Monday, February, 27th 2017.
Who owns Avinger stock?
Avinger's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include FMR LLC (6.84%), Thornburg Investment Management Inc. (6.36%), Alyeska Investment Group L.P. (1.67%), Millrace Asset Group Inc. (0.96%), State Street Corp (0.74%) and First Light Asset Management LLC (0.19%). Company insiders that own Avinger stock include Donald A Lucas, Himanshu Patel, Jeffrey M Soinski, John B Ph D Md Simpson, John D Simpson and Matthew Ferguson.
Who sold Avinger stock? Who is selling Avinger stock?
Avinger's stock was sold by a variety of institutional investors in the last quarter, including Thornburg Investment Management Inc. and First Light Asset Management LLC. Company insiders that have sold Avinger stock in the last year include Donald A Lucas, Himanshu Patel and John B Ph D Md Simpson.
Who bought Avinger stock? Who is buying Avinger stock?
Avinger's stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Millrace Asset Group Inc., State Street Corp and Alyeska Investment Group L.P.. Company insiders that have bought Avinger stock in the last two years include Jeffrey M Soinski, John D Simpson and Matthew Ferguson.
How do I buy Avinger stock?
Shares of Avinger can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Avinger stock cost?
One share of Avinger stock can currently be purchased for approximately $2.40.